Engage in the Latest Innovations and Developments in Wearable Injectors and Connected Devices This September in Boston!
The 3rd Annual Wearable Injectors and Connected Devices USA Conference will return to Boston for 2025 on the 8th and 9th of September, bringing you the latest advances in connected on body drug delivery.
Join leading experts from the injectable drug delivery and digital health sectors for a two-day exploration of the latest advancements in the field. Dive into sessions on large-volume drug delivery technologies, digital integration, and user-centric design, featuring expert insights, real-world case studies, and opportunities for collaboration.
As part of the leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry.
Make sure you don't miss out by attending this event in September 2025!
2025 Speakers
- Anjana Wills, Head of Device Combination Products and Software Quality, AstraZeneca
- Cheng Yang, Digital Diagnostics Lead, Drug Product and Device Development, R&D, Takeda
- Cindy Tritton, Project Lead, Senior Engineer III, Technical Development, Biogen
- Confirmed Senior Representative, BioPhorum
- Deep Bhattacharya, Principal Scientist Formulation and Process Development - Biotherapeutics, Pfizer
- Ellie Younger, Associate Principal Engineer, AstraZeneca
- George Currier, Senior Principal Scientist, Device Development, Bristol Myers Squibb
- Harry Jiang, Device Engineering Lead, Alexion Pharmaceuticals
- Jia Huang, Associate Director, Merck & Co.
- Khaudeja Bano, Vice President - Global Head of Device Quality, Roche-Genentech
- Lipa Shah, Director Science and Technology, Novartis Pharmaceuticals Inc
- Mark Harycki, Senior Director, Device Portfolio and Program Management, Eli Lilly and Company
- Michael Price, Associate Director, Human Factors, AstraZeneca
- Paul Upham, Global Head of Smart Devices, Roche-Genentech
- Prasad Peri, AVP Regualtory Affairs Connected Delivery, Devices and Digital Health, Eli Lilly
- Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
- Sharmad Joshi, Senior Engineer II Device Development, Alexion AstraZeneca Rare Disease
- Sriram Natarjaan, Sr. Manager, Product Quality Management, Johnson & Johnson
- Yvette Appleby, Senior Manager, Digital Health & PMO, Pfizer
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Courtyard by Marriott Boston Downtown
275 Tremont St, 02116
Boston, MA, USA
